Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -16768.8% | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 514.3 | n/a |
Pr/Book | 5.7 |
Latest | F'cast | |
---|---|---|
Revenue | 272.9% | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-20 | n/a | (1.57) | (0.96)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | n/a | (1.84) | (0.85)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-22 | n/a | (1.19) | (0.55)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-23 | n/a | (1.42) | (0.52)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-24 | 0.01 | (1.22) | (0.31)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Final Results, Annual Report and Notice of AGM | 06-Jun-2025 | 07:00 | RNS |
TR-1: Notification of major holdings | 23-May-2025 | 12:37 | RNS |
Holding(s) in Company | 21-May-2025 | 16:11 | RNS |
N4 Pharma reports narrower full-year operating l... | 06-Jun-2025 | ShareCast |
N4 Pharma files for new UK patent | 04-Dec-2024 | ShareCast |
N4 Pharma reports positive progress with SRI col... | 20-Aug-2024 | ShareCast |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 0.45p |
Change Today | 0.005p |
% Change | -1.01 % |
52 Week High | 3.07 |
52 Week Low | 0.40 |
Volume | 43,200 |
Shares Issued | 832.28m |
Market Cap | £3.71m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
09:30 | 200 @ 0.50p |
08:44 | 40,000 @ 0.44p |
08:36 | 300 @ 0.50p |
08:35 | 2,700 @ 0.40p |
You are here: research